Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is the second lethal cancer worldwide, with over 60 million new patients added annually. Hepatitis B infection and toxins, e.g., aflatoxin, contribute to the incidence of HCC. Egypt and China show the highest prevalence of viral hepatitis and HCC in the world. Long non...

Full description

Saved in:
Bibliographic Details
Main Author: El kramani, Nabila Mohamed Hosni
Format: Thesis
Published: AUC Knowledge Fountain 2025
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867613424237674496
access_status_str Open Access
author El kramani, Nabila Mohamed Hosni
author_browse El kramani, Nabila Mohamed Hosni
author_facet El kramani, Nabila Mohamed Hosni
author_sort El kramani, Nabila Mohamed Hosni
collection Thesis
description Hepatocellular carcinoma (HCC) is the second lethal cancer worldwide, with over 60 million new patients added annually. Hepatitis B infection and toxins, e.g., aflatoxin, contribute to the incidence of HCC. Egypt and China show the highest prevalence of viral hepatitis and HCC in the world. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts larger than 200 nucleotides. These transcripts work at the transcriptional, post-transcriptional, and epigenetic levels to regulate gene expression by interacting with various biomolecules, such as RNA, DNA, and proteins. They serve essential functions in chromatin remodeling and cell survival, differentiation, and proliferation. The role and biological interactions of lncRNAs, especially in HCC, are complex. Evidence suggests that aberrant expression of lncRNAs is linked to the incidence, invasiveness, and metastasis of HCC. LncRNAs also have potential use as markers for early detection of HCC. The majority of HCC cases are discovered late at an advanced stage due to the lack of early diagnostic markers. Studies suggest that the diagnostic accuracy of lncRNAs may be affected by many factors, including viral co-infections of patients with HCC. However, differences in the diagnostic accuracy of lncRNAs between Asian and African countries are not statistically significant. The roles of lncRNAs in HCC have been reported to be associated with tumor growth and proliferation (such as HULC, MEG3, CCAT1, PVT1, and PTENP1) and associated with metastasis and prognosis (such as H19, MALAT1, HOTAIR, HOTTIP, HEIH, and lncRNA-p21). This study investigates the potential role of some lncRNAs that are known to be aberrantly expressed in human HCC tissues to identify suitable candidates for future use as diagnostic, prognostic, and therapeutic tools in HCC.
format Thesis
id oai:fount.aucegypt.edu:etds-3442
institution American University in Cairo (Egypt)
last_indexed 2026-06-10T12:35:55.364Z
license_str Not specified — see source repository
provenance_str_mv Harvested via OAI-PMH from AUC Knowledge Fountain — bepress
publishDate 2025
publishDateRange 2025
publishDateSort 2025
publisher AUC Knowledge Fountain
publisherStr AUC Knowledge Fountain
record_format dspace
source_str AUC Knowledge Fountain — bepress
spelling oai:fount.aucegypt.edu:etds-3442 The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma El kramani, Nabila Mohamed Hosni Hepatocellular carcinoma (HCC) is the second lethal cancer worldwide, with over 60 million new patients added annually. Hepatitis B infection and toxins, e.g., aflatoxin, contribute to the incidence of HCC. Egypt and China show the highest prevalence of viral hepatitis and HCC in the world. Long non-coding RNAs (lncRNAs) are non-protein-coding transcripts larger than 200 nucleotides. These transcripts work at the transcriptional, post-transcriptional, and epigenetic levels to regulate gene expression by interacting with various biomolecules, such as RNA, DNA, and proteins. They serve essential functions in chromatin remodeling and cell survival, differentiation, and proliferation. The role and biological interactions of lncRNAs, especially in HCC, are complex. Evidence suggests that aberrant expression of lncRNAs is linked to the incidence, invasiveness, and metastasis of HCC. LncRNAs also have potential use as markers for early detection of HCC. The majority of HCC cases are discovered late at an advanced stage due to the lack of early diagnostic markers. Studies suggest that the diagnostic accuracy of lncRNAs may be affected by many factors, including viral co-infections of patients with HCC. However, differences in the diagnostic accuracy of lncRNAs between Asian and African countries are not statistically significant. The roles of lncRNAs in HCC have been reported to be associated with tumor growth and proliferation (such as HULC, MEG3, CCAT1, PVT1, and PTENP1) and associated with metastasis and prognosis (such as H19, MALAT1, HOTAIR, HOTTIP, HEIH, and lncRNA-p21). This study investigates the potential role of some lncRNAs that are known to be aberrantly expressed in human HCC tissues to identify suitable candidates for future use as diagnostic, prognostic, and therapeutic tools in HCC. 2025-02-19T08:00:00Z dissertation application/pdf https://fount.aucegypt.edu/etds/2399 https://fount.aucegypt.edu/context/etds/article/3442/viewcontent/Nabila_Elkramani_thesis.pdf Theses and Dissertations AUC Knowledge Fountain HCC lncRNAs MEG3 SRHC miR-101-5p miR-216a-5p therapeutic polymer nanoparticles Biotechnology Cell and Developmental Biology
spellingShingle HCC
lncRNAs
MEG3
SRHC
miR-101-5p
miR-216a-5p
therapeutic
polymer nanoparticles
Biotechnology
Cell and Developmental Biology
El kramani, Nabila Mohamed Hosni
The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title_full The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title_fullStr The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title_full_unstemmed The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title_short The Role of Non-coding RNAs as an Innovative Therapeutic Tool for Hepatocellular Carcinoma
title_sort role of non coding rnas as an innovative therapeutic tool for hepatocellular carcinoma
topic HCC
lncRNAs
MEG3
SRHC
miR-101-5p
miR-216a-5p
therapeutic
polymer nanoparticles
Biotechnology
Cell and Developmental Biology
url https://fount.aucegypt.edu/etds/2399
https://fount.aucegypt.edu/context/etds/article/3442/viewcontent/Nabila_Elkramani_thesis.pdf
work_keys_str_mv AT elkramaninabilamohamedhosni theroleofnoncodingrnasasaninnovativetherapeutictoolforhepatocellularcarcinoma
AT elkramaninabilamohamedhosni roleofnoncodingrnasasaninnovativetherapeutictoolforhepatocellularcarcinoma